Home > Healthcare > Healthcare IT > Artificial Intelligence > Artificial Intelligence in Precision Medicine Market

Artificial Intelligence in Precision Medicine Market Analysis

  • Report ID: GMI6012
  • Published Date: Jun 2023
  • Report Format: PDF

Artificial Intelligence in Precision Medicine Market Analysis

By technology, the artificial intelligence in precision medicine market is classified into deep learning, natural language processing, context-aware processing, and querying method. The deep learning segment accounted for 36.5% of the market share in 2022 and is projected to witness robust growth over the analysis timeframe. Deep learning has emerged as a powerful technology in analysing complex and large-scale datasets in the healthcare industry. Its ability to automatically learn and extract high-level representations from data has significant implications for precision medicine, thereby accelerating the market growth. Furthermore, the increasing availability of healthcare data, advancements in computational power, and the development of advanced deep learning models are fuelling the adoption of deep learning in precision medicine thus, boosting the market size.
 

AI in Precision Medicine Market Revenue Share, By Component,

By component, the AI in precision medicine market is classified into software, hardware, and service. The software segment accounted for 53.4% of the business share in 2022 and is projected to witness robust growth over the analysis timeframe. The increasing adoption of AI-based software solutions for precision medicine by healthcare institutions, payers, patients, and providers is anticipated to boost the software segment growth in the market. The advancements in machine learning algorithms, natural language processing, and data integration techniques have enhanced the performance and capabilities of AI software, further driving its growth in precision medicine applications. Furthermore, the increasing collaboration between technology firms, healthcare providers, and research institutions will also contribute to the expansion of the software segment.
 

Based on application, the artificial intelligence in precision medicine market is segmented into oncology, cardiology, neurology, respiratory, and other applications. The oncology segment is expected to register around USD 5.7 billion by 2032. The growing prevalence of cancer cases and the increasing complexity of genomic data are two significant factors expected to drive market progress. For instance, according to the National Institutes of Health (NIH) report, in 2023, 1.9 million new cancer cases and 609,820 cancer deaths are projected to occur in the U.S. only. Therefore, integration of AI in oncology is expected to contribute to more accurate and faster diagnosis of cancer, leading to enhanced patient outcomes.
 

North America AI in Precision Medicine Market Size

North America artificial intelligence in precision medicine market accounted for 51.9% revenue share in 2022 and is anticipated to grow at considerable growth rate during the forecast timeframe. Increasing prevalence of chronic diseases, such as cancer, cardiovascular conditions, and respiratory disorders will drive the market growth. For instance, according to the American Lung Association report, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease). Thus, increasing usage of artificial intelligence in the treatment and diagnosis of chronic diseases will escalate the market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

AI in precision medicine market size reached USD 1.2 billion in 2022 and will amass USD 17.1 billion by 2032 driven by the rising R&D investments and the surging need for personalized medications

The software component segment held 53.4% of the artificial intelligence in precision medicine industry share in 2022 due to higher adoption of AI-based software solutions by healthcare institutions, payers, patients, and providers

AI in precision medicine market size from oncology applications may record USD 5.7 billion by end of 2032 owing to the rising prevalence of cancer cases and the increasing complexity of genomic data

North America recorded 51.9% of the artificial intelligence in precision medicine industry share in 2022 due to the growing frequency of cancer, cardiovascular conditions, and respiratory disorders

Artificial Intelligence (AI) in Precision Medicine Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 213
  • Countries covered: 21
  • Pages: 120
 Download Free Sample